Among 547 episodes of C difficile infection documented in cancer patients in Australia and Spain, 50% were severe, and the 90 ...
Highlights:New Research Collaboration with Monash University One proposal will target Antimicrobial Resistant Pathways to develop broad spectrum ...
People hospitalized for flu should be tested for bird flu within 24 hours, the U.S. Centers for Disease Control and ...
The Centers for Disease Control and Prevention today released an advisory recommending clinicians expedite subtyping of type ...
The latest confirmation likely reflects follow-up testing of a San Francisco child whose exposure to the virus is still under investigation.
The US Centers for Disease Control and Prevention is urging hospitals to accelerate advanced testing of people they suspect may have bird flu. Its alert to doctors and hospitals follows a few rare but ...
Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...
With no approved vaccines to date, C. diff causes nearly 30,000 deaths each year in the US, and recurrent infections with the bacterium make up 10%-15% of all hospital-treated infections.
The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...
Yesterday, the European Centre for Disease Control (ECDC) published an overview of imported mpox clade 1 cases in the ...